The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis
Elizabeth Y. Yuu,Christoph Bührer,Tim Eckmanns,Marcus Fulde,Michaela Herz,Oliver Kurzai,Christin Lindstedt,Gianni Panagiotou,Vitor C. Piro,Aleksandar Radonic,Bernhard Y. Renard,Annicka Reuss,Sara Leal Siliceo,Nadja Thielemann,Andrea Thürmer,Kira van Vorst,Lothar H. Wieler,Sebastian Haller
DOI: https://doi.org/10.1186/s13099-024-00616-w
2024-05-15
Gut Pathogens
Abstract:Enhancing our understanding of the underlying influences of medical interventions on the microbiome, resistome and mycobiome of preterm born infants holds significant potential for advancing infection prevention and treatment strategies. We conducted a prospective quasi-intervention study to better understand how antibiotics, and probiotics, and other medical factors influence the gut development of preterm infants. A controlled neonatal mice model was conducted in parallel, designed to closely reflect and predict exposures. Preterm infants and neonatal mice were stratified into four groups: antibiotics only, probiotics only, antibiotics followed by probiotics, and none of these interventions. Stool samples from both preterm infants and neonatal mice were collected at varying time points and analyzed by 16 S rRNA amplicon sequencing, ITS amplicon sequencing and whole genome shotgun sequencing.
gastroenterology & hepatology,microbiology